The Space Tissue Loss (STL) experiment is a payload to be flown in the middeck of the Shuttle, Atlantis, on the STS-45 mission by the Office of Space Science and Applications (OSSA). The STL experiment is a cooperative effort between OSSA and the Walter Reed Army Institute of Research (WRAIR). The hardware development is sponsored by the United States Army Space Test Program, and the mission management is provided by the United States Air Force Space Systems Division. The primary objective of this flight of the STL experiment is a proof-of-concept of the experiment hardware. Other objectives for this flight include the study of the effects of the microgravity environment on the biochemistry and functional activity of muscle, bone, and blood cells. The STL experiment will also culture appropriate cell lines to develop a cellular model for comparison with whole animal results and test the efficacy of pharmaceuticals to counter tissue loss.


    Access

    Access via TIB

    Check availability in my library


    Export, share and cite



    Title :

    STS-45 OSSA Middeck Payload Experiment Prelaunch Mission Operation Report


    Publication date :

    1992


    Size :

    4 pages


    Type of media :

    Report


    Type of material :

    No indication


    Language :

    English